Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ritch

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group studyH S Hochster, K M Kim, M D Green, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2014
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)T Dragovich, D Laheru, F Dayyani, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 18, 2014
Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancerA N Krepline, K K Christians, K Duelge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2013
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancerB M Wolpin, E M O'Reilly, Y J Ko, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group studyH S Hochster, K M Kim, M D Green, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2014
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)T Dragovich, D Laheru, F Dayyani, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 18, 2014
Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancerA N Krepline, K K Christians, K Duelge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2013
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancerB M Wolpin, E M O'Reilly, Y J Ko, et al.
Pageof 2